Paliperidone palmitate: Experience in a community mental health unit

L. Carrión Expósito; G.M. Chauca Chauca; E.L. Guadalupe

doi:10.1016/j.eurpsy.2017.01.1556

Paliperidone palmitate: Experience in a community mental health unit

Published online by Cambridge University Press: 23 March 2020

L. Carrión Expósito ,

G.M. Chauca Chauca and

E.L. Guadalupe

Show author details

L. Carrión Expósito: Affiliation:
, UGC-Salud Mental Hospital Infanta Margarita, Córdoba, Spain
G.M. Chauca Chauca: Affiliation:
, UGC-Salud Mental Hospital Infanta Margarita, Córdoba, Spain
E.L. Guadalupe: Affiliation:
USMC Cáceres, Hospital Nuestra Señora de la Montaña, Cáceres- Spain, Córdoba, Spain

Article contents

Abstract
Introduction
Objective
Material and method
Results
Conclusions
Disclosure of interest

Abstract

Introduction

There are many jobs that offer advantages of treatment with long-acting injectable in psychosis.

Objective

To know the changes in the different variables after the start of paliperidone palmitate (PP).

Material and method

We performed a descriptive and retrospective study. Were evaluated patients who received maintenance therapy with PP during 48 months.

Results

The sample was composed of 29 patients: 72.4% men and 27.6% women. Average age of 46.21 years. In Figures 1, 2 and 3 show data obtained in relation to compliance with treatment, relapse, maintenance dose, number of admissions and visits to emergency departments respectively.

Conclusions

The administration of PP is associated with a higher level of compliance with treatment. The patients presented a lower number of relapses, hospitalizations and visits to the emergency room. The maintenance dose more used is 150 mg.

Disclosure of interest

The authors have not supplied their declaration of competing interest.